Beyond The Pill

The Beyond the Pill conference provides examples of commercial engagement approaches pharma can use to reach integrated healthcare systems, such as ACOs. It also examines patient-centric marketing solutions pharma can provide that enhance overall outcomes associated with use of innovative new therapies.


"I really believe that in the future, companies like Novartis are going to be paid on patient outcomes as opposed to selling the pill."

Novartis CEO Joseph Jimenez, from interview with The Wall Street Journal.

“Taken together, these changes indicate a future characterized by integrated health-care models that take the concept of intervention ‘beyond the pill’ to more comprehensive approaches that include monitoring, helping with adherence and disease interception. Furthermore, these models could provide a mechanism for society to assess the full costs and benefits of intervention strategies and will allow health-care companies to pilot new integrated solutions in both controlled environments and in the real world.”

Vaibhav A. Narayan, Marco Mohwinckel, Gary Pisano, Michael Yang and Husseini K. Manji - From, Nature Reviews Drug Discovery “Beyond magic bullets: true innovation in health care"